Balancing the Rights of
Pharmaceutical Innovators
& Consumers
Argentum is an evolutionary generic drug company.
We deploy proprietary A.I.
and vast pharma patent litigation
experience to identify and act
against flawed pharmaceutical patents.
We bring products to the
market through our
manufacturing partners
& sales and distribution
partnerships.
We’ve led the charge on the ultimate invalidation of several multi-billion-dollar branded drug franchises, including the remaining final patents protecting Gilenya (fingolimod) and Zytiga (abiraterone acetate).
We are a party to multiple settlements with branded drug companies negotiated in the interest of bringing lower-cost generic drugs to the market sooner than they would otherwise be brought to market.
